semaglutide schizophrenia In a randomized clinical trial published in JAMA Psychiatry, a #GLP1 receptor agonist was assessed in patients with #Schizophrenia who were obese and had prediabetes. Over 30 weeks, GLP-1 Drug Semaglutide Substantially Reduced

empowers New HavenHartfordWaterbury women to embrace vitality by delivering superior care through innovative medicine

Int J Clin Pract

The label literally means the product is not intended for human use

The study showed significant increases in intracellular glutathione levels after just 2 weeks of use, as well as demonstrating its ability to support healthy NK cell function and oxidative stress levels.* Are there any risks to taking liposomal glutathione

No additional updates are warranted to product information for any GLP-1 drug, the agency saidboth Wegovy and Ozempic already indicate on their safety labels the drugs have caused thyroid tumors in studies with rodents, but note it is unknown whether the drugs can cause thyroid tumors or thyroid cancer